PREDICINE HUIDU MEDICAL TECHNOLOGY
Huidu Medical provides development of gene detection methods and bioinformatics algorithms for cancer diagnosis and monitoring, and promotes the development of tumor diagnosis and treatment through our technology.
PREDICINE HUIDU MEDICAL TECHNOLOGY
Industry:
Health Care Medical
Founded:
2016-01-01
Address:
Fengxian, Shanghai, China
Country:
China
Website Url:
http://www.predicine.cn
Total Employee:
1+
Status:
Active
Contact:
+86 21 6718-0693
Technology used in webpage:
Domain Not Resolving
Similar Organizations
Becton Dickinson India
BD is a global medical technology company that is advancing the world of health by improving medical discovery.
DormoTech
DormoTech Medical is a digital health company that specializes in sleep assessment.
Jiuzhentong
Jiuzhentong is a medical technology enterprise that provides an internet medical service platform.
MRK Healthcare Pvt. Ltd.
MRK Healthcare Pvt. Ltd. is a globally recognized medical technology company, focused on creating innovations in the medical devices field.
New NI Medical
New NI Medical is a biotechnology company that develops and manufactures whole body bioimpedance systems.
TaeWoong Medical USA
Taewoong Medical is a medical company that manufactures a vast range of medical equipment and accessories.
Current Employees Featured
Du Pan Co-founder, President and CTO @ Predicine Huidu Medical Technology
Co-founder, President and CTO
2015-01-01
Linh H. Le Chief Financial Officer @ Predicine Huidu Medical Technology
Chief Financial Officer
2021-11-01
Shidong Jia Co-founder, Chairman and CEO @ Predicine Huidu Medical Technology
Co-founder, Chairman and CEO
2015-10-01
Founder
Investors List
Highlight Capital
Highlight Capital investment in Series A - Predicine Huidu Medical Technology
Sangel Capital
Sangel Capital investment in Series A - Predicine Huidu Medical Technology
Xin Ding Capital
Xin Ding Capital investment in Series A - Predicine Huidu Medical Technology
More informations about "Predicine Huidu Medical Technology"
About – Predicine | Advancing Precision Cancer Therapies
Predicine is a molecular insight company developing genomic profiling tests and robust algorithms for cancer diagnostics and monitoring. Our biology-oriented approach to analyzing genomics is advancing the understanding of tumor …See details»
Predicine - Crunchbase Company Profile & Funding
Predicine is a molecular information company developing genomic profiling tests and robust algorithms for cancer diagnostics and monitoring. It has developed …See details»
Predicine 2025 Company Profile: Valuation, Funding
Predicine General Information Description. Developer of precision medicine in oncology designed to provide big data analysis in cancer. The company …See details»
关于我们 – 慧渡医疗 | 精准医学的未来
Predicine is an international precision medicine organization that is committed to developing the first- and best-in-class precision diagnostics and precision medicine portfolio to address the unmet medical needs in the US, China and …See details»
Predicine Huidu Medical Technology - Crunchbase
Predicine Huidu Medical Technology closed its last funding round on Aug 6, 2018 from a Series A round. Who are Predicine Huidu Medical Technology 's competitors? Alternatives and possible competitors to Predicine Huidu …See details»
Home – Predicine | Advancing Precision Cancer Therapies
Predicine’s proprietary GeneRADAR next generation liquid biopsy platform measures cancer-associated genomic blueprint (DNA) and functional biology (RNA) in a single tube of blood to provide more accurate and in-depth …See details»
Predicine Company Profile - Office Locations, Competitors, …
Predicine is a company developing a platform for molecular insights into cancer genomics. It offers GeneRADAR, a liquid biopsy platform that measures cancer-associated genomic …See details»
Predicine - Leadership Team - The Org
The Leadership Team at Predicine is responsible for guiding the company's strategic direction, fostering innovation in liquid biopsy technologies, and ensuring alignment with the mission of …See details»
PredicineATLAS – 慧渡医疗 | 精准医学的未来
通过多种实体瘤临床研究结果显示，慧诠™600基因检测能有效进行cfDNA动态监测，精准检测出高反应患者。左图数据表明胆管癌患者对免疫治疗有应答的患者的等位基因频率（VAF）显著 …See details»
PREDICINE, INC. Company Profile | Hayward, CA - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for PREDICINE, INC. of Hayward, CA. Get the latest business insights from Dun & Bradstreet. PREDICINE, …See details»
Predicine Inc (慧渡医疗) - Tech in Asia
Predicine is an international precision medicine organization that is committed to developing and bringing the first- and best-in-class precision medicine portfolio to address the unmet medical ...See details»
Predicine - 2025 Company Profile, Funding & Competitors - Tracxn
Mar 25, 2025 Predicine is a series B company based in Hayward (United States), founded in 2015 by Du Pan and Shidong Jia. It operates as a Developer of liquid biopsy assays and …See details»
Predicine - Products, Competitors, Financials, Employees, …
Predicine was founded in 2015. Where is Predicine's headquarters? Predicine's headquarters is located at Lane 1698, Wangyuan Road, Shanghai. What is Predicine's latest funding round? …See details»
基因组分析测试方案开发商Predicine推出用于全球临床试验、CDx …
Apr 6, 2024 FDA于2022年批准BDD用于该测定。该试剂盒使用来自液体活组织检查的cfDNA和来自FFPE组织的基因组DNA检测癌症基因中的遗传畸变。Predicine首席执行官贾世东博士强调 …See details»
Through Pharma Collaborations, Predicine Aims to Enter the US
Feb 20, 2024 Predicine has so far limited the use in Europe of its CE-IVD marked PredicineCare assay and PredicineAtlas genomic profiling assay to supporting clinical trials. Jia said the …See details»
Solutions – Overview – Predicine | Advancing Precision Cancer …
We are applying our expertise in genomic profiling to identify elusive cancer-related genetic changes and new biomarker targets across many cancer types.See details»
基因组分析测试方案开发商Predicine宣布与 ... - vbdata.cn
Apr 5, 2024 Predicine是molecular insights的领导者，与Apollomics合作增强PredicineCARE™，这是一种针对NSCLC患者的cfDNA NGS检测方法。该测定法由FDA授 …See details»
Predicine Introduces PredicineCARE™ NGS Kit for Global
Apr 5, 2024 The Predicine portfolio comprises state-of-the-art blood, urine, and tissue-based Next-Generation Sequencing (NGS) assays designed for harmonized global use in research, …See details»
Predicine Partners with FMD to Accelerate Biomarker-Driven …
May 10, 2019 Predicine has developed a breakthrough RNA- and DNA-based liquid biopsy technology for non-invasive cancer profiling, disease monitoring and assessing minimal …See details»
招采详情_招采信息_安徽省招标投标信息网 - ahtba.org.cn
4 days ago 定远县2024年度和美乡村拂晓乡拂晓社区拂晓中心村建设项目招标公告信息See details»